Anti-acetylcholinesterase and Antioxidant Activities of Inhaled Juniper Oil on Amyloid Beta (1–42)-Induced Oxidative Stress in the Rat Hippocampus

Neurochemical Research

Volumn 40, Issue 5, 2015, Pages 952-960

  Cioanca, Oana ^a   Hancianu, Monica ^a   Mihasan, Marius ^b   Hritcu, Lucian ^b  

^a GRIGORE T POPA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^b ALEXANDRU IOAN CUZA UNIVERSITY OF IASI   (Romania)

Author keywords

Alzheimer s disease; Amyloid beta (1 42) peptide; Juniperus communis volatile oil; Oxidative stress

Indexed keywords

ACETYLCHOLINESTERASE; AMYLOID BETA PROTEIN; AMYLOID BETA-PROTEIN (1-42); ANTIOXIDANT; CHOLINESTERASE INHIBITOR; ESSENTIAL OIL; PEPTIDE FRAGMENT; PLANT EXTRACT;

ANIMAL; DRUG EFFECTS; ENZYMOLOGY; HIPPOCAMPUS; INHALATIONAL DRUG ADMINISTRATION; ISOLATION AND PURIFICATION; JUNIPERUS; MALE; METABOLISM; OXIDATIVE STRESS; PHYSIOLOGY; RAT; WISTAR RAT;

ACETYLCHOLINESTERASE; ADMINISTRATION, INHALATION; AMYLOID BETA-PEPTIDES; ANIMALS; ANTIOXIDANTS; CHOLINESTERASE INHIBITORS; HIPPOCAMPUS; JUNIPERUS; MALE; OILS, VOLATILE; OXIDATIVE STRESS; PEPTIDE FRAGMENTS; PLANT EXTRACTS; RATS; RATS, WISTAR;

EID: 84939942852     PISSN: 03643190     EISSN: 15736903     Source Type: Journal    
DOI: 10.1007/s11064-015-1550-0     Document Type: Article

References (43)

1. Everett J, Céspedes E, Shelford LR, Exley C, Collingwood JF, Dobson J, van der Laan G, Jenkins CA, Arenholz E, Telling ND (2014) Ferrous iron formation following the co-aggregation of ferric iron and the Alzheimer’s disease peptide β-amyloid (1–42). J R Soc Interface 11:20140165
2. Shi S-H, Zhao X, Liu B, Li H, Liu A-J, Wu B, Bi K-S, Jia Y (2014) The effects of sesquiterpenes-rich extract of Alpinia oxyphylla Miq. on amyloid-β-induced cognitive impairment and neuronal abnormalities in the cortex and hippocampus of mice. Oxid Med Cell Longev 2014, Article ID 451802, 11 pp
3. Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics. Science 297:353–356
4. Butterfield D, Boyd-Kimball D (2004) Amyloid beta-peptide(1–42) contributes to the oxidative stress and neurodegeneration found in Alzheimer disease brain. Brain Pathol 14:426–432
5. Butterfield DA (2007) Amyloid β-peptide(1–42), oxidative stress, and Alzheimer’s disease. In: Barrow C, Small D (eds) Abeta peptide and Alzheimer’s disease. Springer, London, pp 83–92
6. Mathew M, Subramanian S (2014) In vitro screening for anti-cholinesterase and antioxidant activity of methanolic extracts of ayurvedic medicinal plants used for cognitive disorders. PLoS ONE 9:e86804
7. Li XL, Wang DS, Zhao BQ, Li Q, Qu HY, Zhang T, Zhou JP, Sun MJ (2008) Effects of Chinese herbal medicine fuzhisan on aged rats. Exp Gerontol 43:853–858
8. Butterfield D, Reed T, Newman S, Sultana R (2007) Roles of amyloid β-peptide associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer’s disease and mild cognitive impairment. Free Radic Biol Med 43:658–677
9. Butterfield DA, Swomley AM, Sultana R (2013) Amyloid β-peptide (1–42)-induced oxidative stress in Alzheimer disease: importance in disease pathogenesis and progression. Antioxid Redox Signal 19:823–835
10. Moreira PI, Nunomura A, Nakamura M, Takeda A, Shenk JC, Aliev G, Smith MA, Perry G (2008) Nucleic acid oxidation in Alzheimer disease. Free Radic Biol Med 44:1493–1505
11. Allen DE, Hatfield G (2004) Medicinal plants in folk tradition. An ethnobotany of Britain & Ireland. Timer Press, Cambridge
12. Lesjak MM, Beara IN, Orčić DZ, Anačkov GT, Balog KJ, Francišković MM, Mimica-Dukić NM (2011) Juniperus sibirica Burgsdorf. as a novel source of antioxidant and anti-inflammatory agents. Food Chem 124:850–856
13. Miceli N, Trovato A, Dugo P, Cacciola F, Donato P, Marino A, Bellinghieri V, La Barbera TM, Güvenç A, Taviano MF (2009) Comparative analysis of flavonoid profile, antioxidant and antimicrobial activity of the berries of Juniperus communis L. var. communis and Juniperus communis L. var. saxatilis Pall. from Turkey. J Agric Food Chem 57:6570–6577
14. Akkol EK, Güvenç A, Yesilada E (2009) A comparative study on the antinociceptive and anti-inflammatory activities of five Juniperus taxa. J Ethnopharmacol 125:330–336
15. Öztürk M, Tümen İ, Uǧur A, Aydoǧmuş-Öztürk F, Topçu G (2011) Evaluation of fruit extracts of six Turkish Juniperus species for their antioxidant, anticholinesterase and antimicrobial activities. J Sci Food Agric 91:867–876
16. Moreno L, Bello R, Beltrán B, Calatayud S, Primo-Yúfera E, Esplugues J (1998) Pharmacological screening of different Juniperus oxycedrus L. extracts. Pharmacol Toxicol 82:108–112
17. Cioanca O, Mircea C, Trifan A, Aprotosoaie A, Hritcu L, Hancianu M (2014) Improvement of amyloid-β-induced memory deficits by Juniperuscommunis L. volatile oil in a rat model of Alzheimer’s disease. FARMACIA 62:514–520
18. Cioanca O, Hritcu L, Mihasan M, Trifan A, Hancianu M (2014) Inhalation of coriander volatile oil increased anxiolytic–antidepressant-like behaviors and decreased oxidative status in beta-amyloid (1–42) rat model of Alzheimer’s disease. Physiol Behav 131:68–74
19. Adams RP (2007) Identification of essential oil by gas chromatography/mass spectroscopy. Allured Publishing Corporation, Carol Stream
20. Laursen S, Belknap J (1986) Intracerebroventricular injections in mice. Some methodological refinements. J Pharmacol Methods 16:355–357
21. Paxinos G, Watson S (2005) The rat brain in stereotaxic coordinates. Academic Press, San Diego
22. Linck VdM, da Silva AL, Figueiró M, Luis Piato Â, Paula Herrmann A, Dupont Birck F, Bastos Caramão E, Sávio Nunes D, Moreno PRH, Elisabetsky E (2009) Inhaled linalool-induced sedation in mice. Phytomedicine 16:303–307
23. Barocelli E, Calcina F, Chiavarini M, Impicciatore M, Bruni R, Bianchi A, Ballabeni V (2004) Antinociceptive and gastroprotective effects of inhaled and orally administered Lavandula hybrida Reverchon “Grosso” essential oil. Life Sci 76:213–223
24. Ellman G, Courtney K, Andres VJ, Feather-Stone R (1961) A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 7:88–95
25. Srikumar B, Ramkumar K, Raju T, Shankaranarayana Rao B (2004) Assay of acetylcholinesterase activity in the brain. In: Raju T, Kutty B, Sathyaprabha T, Shanakranarayana Rao B (eds) Brain and behavior. National Institute of Mental Health and Neurosciences, Bangalore, pp 142–144
26. Winterbourn C, Hawkins R, Brian M, Carrell R (1975) The estimation of red cell superoxide dismutase activity. J Lab Clin Med 85:337
27. Sharma M, Gupta Y (2002) Chronic treatment with trans resveratrol prevents intracerebroventricular streptozotocin induced cognitive impairment and oxidative stress in rats. Life Sci 7:2489–2498
28. Sinha A (1972) Colorimetric assay of catalase. Anal Biochem 47:389–394
29. Fukuzawa K, Tokumura A (1976) Glutathione peroxidase activity in tissues of vitamin E-deficient mice. J Nutr Sci Vitaminol 22:405–407
30. Oliver C, Ahn B, Moerman E, Goldstein S, Stadtman E (1987) Age-related changes in oxidized proteins. J Biol Chem 262:5488–5491
31. Luo S, Wehr N (2009) Protein carbonylation: avoiding pitfalls in the 2,4-dinitrophenylhydrazine assay. Redox Rep 14:159–166
32. Ohkawa H, Ohishi N, Yagi K (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351–358
33. Smith P, Krohn R, Hermanson G, Mallia A, Gartner F, Provenzano M, Fujimoto E, Goeke N, Olson B, Klenk D (1985) Measurement of protein using bicinchoninic acid. Anal Biochem 150:76–85
34. Turunc Bayrakdar E, Uyanikgil Y, Kanit L, Koylu E, Yalcin A (2014) Nicotinamide treatment reduces the levels of oxidative stress, apoptosis, and PARP-1 activity in Aβ(1–42)-induced rat model of Alzheimer’s disease. Free Radic Res 48:146–158
35. Cioanca O, Hritcu L, Mihasan M, Hancianu M (2013) Cognitive-enhancing and antioxidant activities of inhaled coriander volatile oil in amyloid β(1–42) rat model of Alzheimer’s disease. Physiol Behav 120:193–202
36. Aazza S, Lyoussi B, Miguel MG (2011) Antioxidant and antiacetylcholinesterase activities of some commercial essential oils and their major compounds. Molecules 16:7672–7690
37. Liu B, Hong JS (2003) Role of microglia in inflammation-mediated neurodegenerative diseases: mechanisms and strategies for therapeutic intervention. Pharmacol Exp Ther 304:1–7
38. Stadtman E (1992) Protein oxidation and aging. Science 257:1220–1224
39. Jhoo JH, Kim H-C, Nabeshima T, Yamada K, Shin E-J, Jhoo W-K, Kim W, Kang K-S, Jo SA, Woo JI (2004) β-Amyloid (1–42)-induced learning and memory deficits in mice: involvement of oxidative burdens in the hippocampus and cerebral cortex. Behav Brain Res 155:185–196
40. Lu P, Mamiya T, Lu LL, Mouri A, Zou LB, Nagai T, Hiramatsu M, Ikejima T, Nabeshima T (2009) Silibinin prevents amyloid β peptide-induced memory impairment and oxidative stress in mice. Br J Pharmacol 157:1270–1277
41. Andersen FA (2001) Final report on the safety assessment of Juniperus communis extract, Juniperus oxycedrus extract, Juniperus oxycedrus Tar, Juniperus phoenicea extract, and Juniperus virginiana extract. Int J Toxicol 20:41–56
42. Schilcher H, Leuschner F (1997) Untersuchungen auf mogliche nephrotoxische Wirkungen von aetherischem Wacholderbeerol. Arzneim Forsch 47:855–858
43. Tisserand R, Young R (2014) 13-Essential oil profiles. In: Young RT (ed) Essential oil safety, 2nd edn. Churchill Livingstone, St. Louis, pp 187–482